Advertisement

Topics

BIOPHARM GmBH Company Profile

23:59 EST 18th November 2017 | BioPortfolio

Our vision is to combat illnesses using substances that nature provides for that purpose. Our path to achieving this is through biotechnology, i.e. using genetic information to create safe and innovative active agents from the body’s own substances.

We are passionate researchers and developers. In the development of innovative drugs and treatment methods based on recombinant molecules such as rhGDF-5/MP52, we can count on our competent and committed team and the good cooperation with our license and cooperation partners.

As an independent private company, we are not dependent on the capital markets. That means that we have a duty only to our clients, our personnel and the achievement of our goals.

Location

Czernyring 22
Heidelberg
69115
Germany

Contact

Phone: +49 (0) 6221 53 83-0
Fax: +49 (0) 6221 53 83-20
Email: info@biopharm.de


News Articles [187 Associated News Articles listed on BioPortfolio]

EU Horizon grants $4.7M to TC BioPharm for cancer study

The European Union's Horizon 2020 has granted $4.7 million to TC BioPharm to advance the latter's gamma-delta T cell OmnImmun -More- 

EU Horizon grants $4.7M to TB BioPharm for cancer study

The European Union's Horizon 2020 has granted $4.7 million to TC BioPharm to advance the latter's gamma-delta T cell OmnImmun -More- 

FREE TICKET Giveaway for BioPharm America 2017!

If you haven’t heard of this event, here’s what you need to know: BioPharm America™ is an international partnering conference with focus on the life sciences in Boston, Massachusetts, that is ta...

And the Winner for the BioPharm America 2017 FREE Ticket Giveaway is…

Three weeks ago, on July 26th, we published the free ticket giveaway for the BioPharm America conference in Boston, Massachusetts, which is taking place from September 26th – 27th, 2017! Today,...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

TC BioPharm Selected For EU Horizon 2020 Funding To Progress Novel, Mass-Market Cell Therapies To Clinical Trial

4million grant would allow Scottish company to develop next-generation cancer therapies for multiple tumour types Funding represents the largest EU-award to any UK company for development of a healthc...

TC Biopharm Selected For EU Horizon 2020 Funding To Progress Novel, Mass-Market Cell Therapies To Clinical Trial

4million grant would allow Scottish company to develop next-generation cancer therapies for multiple tumour types Funding represents the largest EU-award to any UK company for development of a healthc...

BioPharm America™ Global Partnering Event Gives Attending Companies Direct Contact With Biotech Innovation, Pharma Executives and Funding Sources

Carlsbad, CA (PRWEB) August 24, 2017 In one month, 800+ life science leaders will gather in Boston for the tenth annual BioPharm Ame...

PubMed Articles [19 Associated PubMed Articles listed on BioPortfolio]

Corrigendum to "Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line" Eur. J. Pharm. Biopharm. 119 (2017) 253-263.

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Cyclic and Torsional Fatigue Resistance of Reciprocating Single Files Manufactured by Different Nickel-titanium Alloys.

The aim of this study was to evaluate the cyclic and torsional fatigue resistance of the following reciprocating single-file systems: ProDesign R 25.06 (Easy Equipamentos Odontológicos, Belo Horizont...

Clinical Trials [39 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Influence of Non-invasive Neurostimulation (Transcutaneous Vagus Nerve Stimulation) on 1. the Noradrenergic Release in the Brain and 2. a Neuropsychological Memory Task

The goal of this study is to investigate the influence of transcutaneous vagus nerve stimulation 1. on the noradrenergic system in the brain and 2. on memory, in healthy volunteers. ...

Companies [554 Associated Companies listed on BioPortfolio]

BioPharm Services US

BioPharm Services was first registered in 1998 and now employs more than 10 people in 2 offices in the US and UK. The company provides a broad spectrum of consultancy services covering all aspects of ...

R-Biopharm Inc.

R-Biopharm AG was founded in 1988 as a subsidiary of the company Röhm AG in Darmstadt. In 1991 R-Biopharm was acquired by Dr. Ralf Dreher through a management buy out. The main activity is the develo...

TTY Biopharm

TTY Biopharm stands to innovate the industry,emerge anew from the ashes of self-kindled flames, and accept multi challenges, encourage enterprising ventures, and share its knowledge and information.

Biopharm

Biopharm is a multinational company founded in 1995 by a group of scientists and business executives with the vision of developing innovative natural nutraceuticals that are backed by solid scientific...

BioPharm Insight

BioPharm Insight is the most comprehensive life science market intelligence and analytics solution, featuring a team of investigative journalists writing exclusive news and thousa...

More Information about "BIOPHARM GmBH" on BioPortfolio

We have published hundreds of BIOPHARM GmBH news stories on BioPortfolio along with dozens of BIOPHARM GmBH Clinical Trials and PubMed Articles about BIOPHARM GmBH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BIOPHARM GmBH Companies in our database. You can also find out about relevant BIOPHARM GmBH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record